| Preclinical Safety Evaluation of Oncolytic Herpes Simplex Virus Type 2 | |
| Wang, Yang; Zhou, Xiaobing; Wu, Zhen; Hu, Han; Jin, Jing; Hu, Yanping; Dong, Yuting; Zou, Jianwen; Mao, Zeyong; Shi, Xiaotai | |
| 2019 | |
| 卷号 | 30期号:5页码:651-660 |
| 关键词 | herpes simplex virus type 2 safety evaluation antitumor effect |
| ISSN号 | 1043-0342 |
| DOI | 10.1089/hum.2018.170 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE ; PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6345595 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Wang, Yang,Zhou, Xiaobing,Wu, Zhen,et al. Preclinical Safety Evaluation of Oncolytic Herpes Simplex Virus Type 2[J],2019,30(5):651-660. |
| APA | Wang, Yang.,Zhou, Xiaobing.,Wu, Zhen.,Hu, Han.,Jin, Jing.,...&Liu, Binlei.(2019).Preclinical Safety Evaluation of Oncolytic Herpes Simplex Virus Type 2.,30(5),651-660. |
| MLA | Wang, Yang,et al."Preclinical Safety Evaluation of Oncolytic Herpes Simplex Virus Type 2".30.5(2019):651-660. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论